Ensysce Biosciences (ENSC) Receivables - Other (2021 - 2025)
Historic Receivables - Other for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to $4411.0.
- Ensysce Biosciences' Receivables - Other fell 9975.26% to $4411.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4411.0, marking a year-over-year decrease of 9975.26%. This contributed to the annual value of $124115.0 for FY2024, which is 2721.78% up from last year.
- Latest data reveals that Ensysce Biosciences reported Receivables - Other of $4411.0 as of Q3 2025, which was down 9975.26% from $1.2 million recorded in Q2 2025.
- Ensysce Biosciences' 5-year Receivables - Other high stood at $1.8 million for Q3 2024, and its period low was $4411.0 during Q3 2025.
- Its 5-year average for Receivables - Other is $339190.7, with a median of $132464.0 in 2022.
- Per our database at Business Quant, Ensysce Biosciences' Receivables - Other soared by 155475.97% in 2024 and then crashed by 9975.26% in 2025.
- Quarter analysis of 5 years shows Ensysce Biosciences' Receivables - Other stood at $441721.0 in 2021, then plummeted by 37.33% to $276821.0 in 2022, then plummeted by 64.76% to $97561.0 in 2023, then increased by 27.22% to $124115.0 in 2024, then plummeted by 96.45% to $4411.0 in 2025.
- Its Receivables - Other stands at $4411.0 for Q3 2025, versus $1.2 million for Q2 2025 and $22002.0 for Q1 2025.